From: Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
 | Gallbladder Cancer (32) | Intra-hepatic CC (24) | Perihilar CC (3) | Middle CBD and Intrapancreatic CC (13) |
---|---|---|---|---|
KRAS | 0 (0%) | 3 (13%) | 1 (33%) | 0 (0%) |
NRAS | 2 (6.3%) | 1 (4%) | 0 (0%) | 0 (0%) |
PIK3CA | 4 (12.5%) | 0 (0%) | 0 (0%) | 0 (0%) |